Summit Trail Advisors, LLC Novartis Ag Transaction History
Summit Trail Advisors, LLC
- $5.73 Billion
- Q2 2025
A detailed history of Summit Trail Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 6,557 shares of NVS stock, worth $811,691. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,557
Previous 6,360
3.1%
Holding current value
$811,691
Previous $709,000
11.85%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding NVS
# of Institutions
1,582Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.32 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.29 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.12 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$936 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$882 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $266B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...